| Symbol | TECH |
|---|---|
| Name | BIO-TECHNE CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 614 MCKINLEY PLACE N.E., MINNEAPOLIS, Minnesota, 55413, United States |
| Telephone | +1 612 379-8854 |
| Fax | — |
| — | |
| Website | https://www.bio-techne.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000842023 |
| Description | Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Additional info from NASDAQ: |
New Form DEFA14A - BIO-TECHNE Corp <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001140361-26-035490 <b>Size:</b> 53 KB
Read moreBio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
Read moreBio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
Read moreNew Form DEFA14A - BIO-TECHNE Corp <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001140361-26-034325 <b>Size:</b> 19 KB
Read moreTECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders
Read moreNew Form DEFM14A - BIO-TECHNE Corp <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001140361-26-033911 <b>Size:</b> 4 MB
Read moreBohnen Shane 🟢 acquired 68.9K shares (14 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($5.1M) Transaction Date: Aug 17, 2026 | Filing ID: 000134
Read moreDirector Kelderman Kim 🟢 acquired 455.7K shares (16 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($31.9M) Transaction Date: Aug 17, 2026 | Filing ID: 000133
Read moreHippel James 🟢 acquired 402.9K shares (14 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($28.9M) Transaction Date: Aug 17, 2026 | Filing ID: 000132
Read moreDirector Herr Amy E. 🟢 acquired 20.0K shares (13 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($1.5M) Transaction Date: Aug 17, 2026 | Filing ID: 000131
Read more